{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:16Z","timestamp":1786654096656,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004350","name":"German National Merit Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118271","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:10:00Z","timestamp":1784329800000},"page":"118271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chimeric analysis links increased NO sensitivity to GC-2 domains and higher maximal activity to GC-1"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1948-2065","authenticated-orcid":false,"given":"Svenja","family":"Stomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-0729","authenticated-orcid":false,"given":"S\u00f6nke","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118271_b0005","doi-asserted-by":"crossref","first-page":"L450","DOI":"10.1152\/ajplung.00404.2021","article-title":"The differential roles of the two NO-GC isoforms in adjusting airway reactivity","volume":"323","author":"Verheyen","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bcp.2026.118271_b0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0898-6568(02)00078-5","article-title":"Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain","author":"Mergia","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.118271_b0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/j.pain.0000000000001440","article-title":"Distinct functions of soluble guanylyl cyclase isoforms NO-GC1 and NO-GC2 in inflammatory and neuropathic pain processing","volume":"160","author":"Petersen","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2026.118271_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177557","article-title":"Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat","volume":"996","author":"Stomberg","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118271_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejn.15564","article-title":"Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2","volume":"55","author":"Giesen","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2026.118271_b0030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1523\/JNEUROSCI.4706-06.2007","article-title":"Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases","volume":"27","author":"Haghikia","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2026.118271_b0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj3350125","article-title":"Functional properties of a naturally occurring isoform of soluble guanylyl cyclase","author":"Russwurm","year":"1998","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2026.118271_b0040","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cellsig.2007.06.017","article-title":"The \u03b12\u03b21 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling","volume":"19","author":"Bellingham","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.118271_b0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(91)80871-Y","article-title":"Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme","volume":"292","author":"Harteneck","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2026.118271_b0050","doi-asserted-by":"crossref","first-page":"21109","DOI":"10.1074\/jbc.270.36.21109","article-title":"A Variant of the alpha-2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein","author":"Behrends","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118271_b0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0167-4781(00)00211-6","article-title":"Cloning and functional expression of the rat a2 subunit of soluble guanylyl cyclase","author":"Koglin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118271_b0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2017.11.010","article-title":"BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs","volume":"147","author":"S\u00f6mmer","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118271_b0065","doi-asserted-by":"crossref","first-page":"30737","DOI":"10.1074\/jbc.M102549200","article-title":"Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit","volume":"276","author":"Koglin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118271_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025772","article-title":"The amino-terminus of nitric oxide sensitive guanylyl cyclase \u03b11 does not affect dimerization but influences subcellular localization","volume":"6","author":"Kraehling","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118271_b0075","first-page":"1511","article-title":"High sensitive and fast protein detection with coomassie brilliant blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis","author":"Kang","year":"2002","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.bcp.2026.118271_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the \u22c5NO\/cGMP signaling pathway","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118271_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/protein\/gzg045","article-title":"Complex chimeras to map ligand binding sites of GPCRs","volume":"16","author":"Gearing","year":"2003","journal-title":"Protein Eng."},{"key":"10.1016\/j.bcp.2026.118271_b0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pro.95","article-title":"Structural and functional modularity of proteins in the de novo purine biosynthetic pathway","volume":"18","author":"Li","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.bcp.2026.118271_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173203","article-title":"Tyrosine 135 of the \u03b21 subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs","volume":"881","author":"R\u00fchle","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118271_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030471","article-title":"Cellular factors that shape the activity or function of nitric oxide-stimulated soluble guanylyl cyclase","volume":"12","author":"Sharina","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118271_b0105","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1074\/jbc.M411545200","article-title":"Characterization of a novel type of endogenous activator of soluble guanylyl cyclase","volume":"280","author":"Balashova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118271_b0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.str.2014.01.008","article-title":"Nitric oxide-induced conformational changes in soluble guanylate cyclase","volume":"22","author":"Underbakke","year":"2014","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2026.118271_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/ars.2016.6693","article-title":"Structure and activation of soluble guanylyl cyclase, the nitric oxide sensor","volume":"26","author":"Montfort","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2026.118271_b0120","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1074\/jbc.M212740200","article-title":"A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding","volume":"278","author":"Koglin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118271_b0125","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1074\/jbc.M710269200","article-title":"Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity","volume":"283","author":"Sharina","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118271_b0130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1089\/scd.2010.0411","article-title":"Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells","volume":"20","author":"Sharin","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bcp.2026.118271_b0135","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1006\/bbrc.2002.6764","article-title":"BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase","volume":"292","author":"Koglin","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118271_b0140","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1074\/jbc.M706218200","article-title":"PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure","volume":"283","author":"Ma","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118271_b0145","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.str.2009.08.011","article-title":"Structure and signaling mechanism of Per-ARNT-Sim domains","volume":"17","author":"M\u00f6glich","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2026.118271_b0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","article-title":"Structural insights into the mechanism of human soluble guanylate cyclase","volume":"574","author":"Kang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118271_b0155","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/bi301570m","article-title":"Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking","volume":"52","author":"Fritz","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118271_b0160","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/acs.biochem.3c00052","article-title":"Role of the coiled-coil domain in allosteric activity regulation in soluble guanylate cyclase","volume":"62","author":"Wittenborn","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118271_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.niox.2018.04.008","article-title":"Structure\/function of the soluble guanylyl cyclase catalytic domain","volume":"77","author":"Childers","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2026.118271_b0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1113\/jphysiol.2005.089755","article-title":"The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function","volume":"568","author":"Pyke","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2026.118271_b0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mnh.0000441048.91041.3a","article-title":"New insights into the role of soluble guanylate cyclase in blood pressure regulation","volume":"23","author":"Buys","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bcp.2026.118271_b0180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.20745","article-title":"SERCA pump isoforms: their role in calcium transport and disease","volume":"35","author":"Periasamy","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bcp.2026.118271_b0185","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/emboj\/18.5.1303","article-title":"Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes","author":"Miyakawa","year":"1999","journal-title":"EMBO J."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:22:36Z","timestamp":1786652556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0006295226006106"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118271","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric analysis links increased NO sensitivity to GC-2 domains and higher maximal activity to GC-1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118271"}}